ABCL
Price
$3.62
Change
+$0.29 (+8.71%)
Updated
Jun 24, 12:47 PM (EDT)
Capitalization
993.95M
49 days until earnings call
PRAX
Price
$42.44
Change
+$0.81 (+1.95%)
Updated
Jun 24, 12:53 PM (EDT)
Capitalization
862.42M
56 days until earnings call
Interact to see
Advertisement

ABCL vs PRAX

Header iconABCL vs PRAX Comparison
Open Charts ABCL vs PRAXBanner chart's image
AbCellera Biologics
Price$3.62
Change+$0.29 (+8.71%)
Volume$6.02K
Capitalization993.95M
Praxis Precision Medicines
Price$42.44
Change+$0.81 (+1.95%)
Volume$100
Capitalization862.42M
ABCL vs PRAX Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. PRAX commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and PRAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2025
Stock price -- (ABCL: $3.33 vs. PRAX: $41.63)
Brand notoriety: ABCL and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 103% vs. PRAX: 68%
Market capitalization -- ABCL: $993.95M vs. PRAX: $862.42M
ABCL [@Biotechnology] is valued at $993.95M. PRAX’s [@Biotechnology] market capitalization is $862.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABCL and PRAX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while PRAX’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 5 bearish.
  • PRAX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than PRAX.

Price Growth

ABCL (@Biotechnology) experienced а +5.38% price change this week, while PRAX (@Biotechnology) price change was -4.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +34.44%, and the average quarterly price growth was +16.31%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

PRAX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($994M) has a higher market cap than PRAX($862M). ABCL YTD gains are higher at: 13.652 vs. PRAX (-45.907). ABCL has higher annual earnings (EBITDA): -211.2M vs. PRAX (-232.71M). ABCL has more cash in the bank: 605M vs. PRAX (328M). PRAX has less debt than ABCL: PRAX (1.07M) vs ABCL (67.8M). ABCL has higher revenues than PRAX: ABCL (23.1M) vs PRAX (8.12M).
ABCLPRAXABCL / PRAX
Capitalization994M862M115%
EBITDA-211.2M-232.71M91%
Gain YTD13.652-45.907-30%
P/E RatioN/AN/A-
Revenue23.1M8.12M284%
Total Cash605M328M184%
Total Debt67.8M1.07M6,360%
TECHNICAL ANALYSIS
Technical Analysis
ABCLPRAX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 14 days ago
76%
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYMCX7.610.08
+1.06%
Royce Micro-Cap Consult
SLVAX34.86N/A
N/A
Columbia Select Large Cap Value A
OTCHX29.57N/A
N/A
MFS Mid Cap Growth R3
BCSSX47.71N/A
N/A
Brown Capital Mgmt Small Co Instl
MMMMX39.32N/A
N/A
Victory Integrity Discovery Member

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-2.35%
CRSP - ABCL
62%
Loosely correlated
+2.94%
RXRX - ABCL
58%
Loosely correlated
-3.78%
ABSI - ABCL
57%
Loosely correlated
-1.08%
BEAM - ABCL
56%
Loosely correlated
-0.30%
VCYT - ABCL
56%
Loosely correlated
+1.21%
More

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with CDXS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
-1.68%
CDXS - PRAX
49%
Loosely correlated
+3.06%
MNMD - PRAX
45%
Loosely correlated
-5.74%
DNLI - PRAX
45%
Loosely correlated
-1.94%
ABCL - PRAX
41%
Loosely correlated
-2.35%
XENE - PRAX
40%
Loosely correlated
-1.75%
More